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Protein disulﬁde isomerase (PDI)
Oxidoreductase
Peroxidase
SulfenylationProtein disulﬁde bonds are an important co- and post-translational modiﬁcation for proteins entering the secretory
pathway. They are covalent interactions between two cysteine residues which support structural stability and pro-
mote the assembly of multi-protein complexes. In the mammalian endoplasmic reticulum (ER), disulﬁde bond for-
mation is achieved by the combined action of two types of enzyme: one capable of forming disulﬁdes de novo and
another able to introduce these disulﬁdes into substrates. The initial process of introducing disulﬁdes into substrate
proteins is catalyzed by the protein disulﬁde isomerase (PDI) oxidoreductases which become reduced and, there-
fore, have to be re-oxidized to allow for further rounds of disulﬁde exchange. This review will discuss the various
pathways operating in the ER that facilitate oxidation of the PDI oxidoreductases and ultimately catalyze disulﬁde
bond formation in substrate proteins. This article is part of a Special Issue entitled: Functional and structural diversity
of endoplasmic reticulum.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Newly synthesized proteins fold into functional 3-dimensional con-
formations stabilized by van der Waals interactions, salt bridges, hydro-
gen bonds and the hydrophobic effect. In addition to these non-covalent
interactions, a large number of proteins in the secretory pathway, or
those destined as cell surface receptors, form disulﬁdes; covalent bonds
formed between the side chains of two cysteine residues. Protein disul-
ﬁde bonds are primarily formed as a result of a thiol-disulﬁde exchange
reaction, with PDI exchanging its active site disulﬁde with its substrate.
Potentially any two cysteine residues in close spatial proximity can
form a disulﬁde bond. Therefore, the formation of a native disulﬁde
bond in a polypeptide containing several cysteine residues can be-
come problematic. Non-native disulﬁdes can prevent correct folding
and have to be reduced or isomerized to form the correct, native
disulﬁdes [1,2]. Hence, the formation of native disulﬁdes is often a rate-
limiting step during the folding and maturation of many disulﬁde-
containing secretory proteins [3,4].
Disulﬁde bonds are crucial for the biosynthesis and function of many
proteins. They promote structural stability, facilitate the assembly of
multi-protein complexes and can modulate redox-dependent functions
in response to changes in the cell [5]. Disulﬁde bonds can also mediate
the formation of productive folding intermediates, and have been
shown in the ER to promote thiol-mediated protein retention [6,7].onal and structural diversity of
: +44 141 330 5481.
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rights reserved.These functions illustrate the importance of disulﬁde bonds in numerous
cellular processes and highlight the need for a proper understanding of
the proteins involved and the mechanisms regulating their formation.
In the last few decades, signiﬁcant progress has been made toward
unraveling the mechanistic details of protein disulﬁde bond formation
in prokaryotic and eukaryotic organisms. Thus we now know that
enzyme-catalyzed disulﬁde bonds can be formed in a number of spe-
cialized cellular locations, including the endoplasmic reticulum, the
bacterial periplasm [8] and the inter-membrane space of themitochon-
dria [9]. While signiﬁcant progress has beenmade in understanding the
enzyme-catalyzed oxidative pathways operating in the ER, no corre-
sponding reduction pathways operating in this organelle have been
identiﬁed to date.
2. Environment of the ER and disulﬁde bond formation
The environment of the ER is distinct from the cytosol in two impor-
tant aspects that ensure the formation of disulﬁde bonds in proteins
translocated across the ER membrane; namely the presence of an opti-
mized redox buffer and disulﬁde exchange proteins. Like the cytosol,
the ER contains a redox buffer, maintained by the cysteine-containing
tripeptide, glutathione (γ-L-glutamyl-L-cysteinylglycine). However, un-
like the cytosol the glutathione buffer ismuchmore oxidizing. In the cy-
tosol, glutathione is predominantly in the reduced form (GSH) with
only very low concentrations of oxidized glutathione (GSSG) [10]. A
high GSH:GSSG ratio is maintained by a robust reductive pathway
consisting of glutathione reductase coupled to NADPH. Such a system,
in general, prevents disulﬁde formation. In addition, thioredoxin and
thioredoxin reductase coupled to NADPH act to reduce any disulﬁdes
formed within cytosolic proteins [11]. In contrast, the ER contains no
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consequence theGSH:GSSG ratio ismuch lower anddisulﬁdes can form.
In addition, most of the thioredoxin domain-containing proteins pres-
ent in the ER are more likely to form than break disulﬁdes due to the
more positive reduction potential of their active sites than cytosolic
thioredoxin. For example, the active site disulﬁde of thioredoxin has a
reduction potential of approximately−270 mV [12]whereas the active
site disulﬁde of PDI has a reduction potential of approximately −
165 mV [13]. This means that the thioredoxin disulﬁde is more stable
than the PDI disulﬁde so PDI is more likely to exchange its disulﬁde
with a substrate protein rather than reduce an existing disulﬁde.
In addition to providing an environment for disulﬁde formation, the
ER contains proteins that are dedicated to protein folding [14–16]. Such
folding factors can form multi-protein complexes that act in concert to
allow folding and disulﬁde formation in newly synthesized proteins.
Many of these folding factors, such as BiP, calnexin and calreticulin, do
not catalyze protein folding, but rather shield newly synthesized pro-
teins from other competing ‘off pathways’ such as aggregation, thereby
maintaining newly synthesized polypeptides in a ‘folding competent’
conformation [16].3. PDI thiol-disulﬁde oxidoreductase family
Disulﬁde bond formation in the ER is catalyzed by the PDI family of
dithiol-disulﬁde oxidoreductases [17]. About 20 proteins have been
assigned to this family to date; with 15 members containing the typical
thioredoxin-like fold, with characteristic CXXC motifs in their active
site. The number and position of the thioredoxin domains and their ac-
tive site chemistries vary depending on the particular enzyme [17].
These proteins catalyze thiol-disulﬁde exchange reactions by acting as
electron acceptors during disulﬁde bond formation (oxidation reaction)
or as electron donors during breaking of disulﬁdes (reduction reaction).
The PDI proteins also catalyze isomerization reactions by rearranging
non-native to native disulﬁdes. The ability of a particular PDI enzyme
to act as an oxidant or a reductant depends in part on the redox potential
of the CXXC active site [13,18]. As mentioned previously, the majority of
PDI proteins contain active sites disulﬁdes that are relatively unstable in
comparison to the CXPCmotif of cytosolic thioredoxin [19]. A notable ex-
ception is ERdj5, which contains four CXXC motifs, with three of these
containing the CXPCmotif [20]. Consistent with the similarity to cytosol-
ic thioredoxin, the active site disulﬁdes in ERdj5 are quite stable and this
enzyme has been shown to act as a reductant, breaking disulﬁdes to fa-
cilitate the unfolding of proteins destined for degradation in the cytosol
[21]. While it was thought the functions of some of the PDI proteins
would be redundant because of the similarities in their active sites,
there is now accumulating evidence for substrate speciﬁcities and de-
ﬁned roles [22].
PDI was the ﬁrst ER oxidoreductase to be extensively characterized. It
is an essential enzyme in yeast, and has been shown to function as a chap-
erone as well as introduce disulﬁde bonds into substrates [23–25]. PDI
contains four thioredoxin-like domains namely a, b, b′, and a′. Only the
a and a′ domains contain the canonical CXXC active site motif [18]. The
low pKa of the ﬁrst cysteine of the CXXC motif allows this residue to par-
ticipate in disulﬁde bond formation [26]. The crystal structure of both a re-
duced and oxidized version of the humanprotein has been solved [27,28].
Overall the four PDI domains form a twisted ‘U’ conformation, with the
catalytic domains a and a′ situated at the top, facing each other; while
the domains b and b′, are sandwiched between the catalytic domains,
on the inside of the ‘U’ [28]. The interior of the U is hydrophobic, particu-
larly at the b and b′ domains and is the principal binding site for peptides
and misfolded regions of substrates [29]. However, other domains of PDI
have been implicated in substrate binding [30]. The presence of such hy-
drophobic regions explains how in addition to facilitating disulﬁde forma-
tion in newly synthesized proteins, PDImay also function as a chaperone,
inhibiting aggregation of misfolded proteins [31].Conformational differences between the reduced and oxidized
human PDI indicate a large inter-domain rotation around the a′b′ region
resulting in a transition from an open (oxidized) to a closed (reduced)
structure (Fig. 1). In the open conformation the binding cleft could ac-
commodate larger polypeptideswhichmay have folded but not formed
their disulﬁdes. In contrast, the binding cleft in the reduced protein is
much smaller restricting binding to smaller or less folded polypeptides.
Such conformational changes are intriguing andmay indicate a possible
mechanism to ensure the release of polypeptides from PDI once the di-
sulﬁde transfer has occurred. Indeed a recent paper using amodel single
domain protein with one disulﬁde bond indicates that protein folding
occurs prior to disulﬁde formation [2]. While this work used a single
domain of PDI as the catalyst, the basic premise that folding occurs
prior to disulﬁde formation would necessitate a large binding cleft
within full-length PDI to accommodate the folded polypeptide
substrate.
When PDI and other oxidoreductases introduce disulﬁdes into newly
synthesized proteins, their active sites have to be re-oxidized to allow for
further rounds of disulﬁde formation. This function is fulﬁlled by speciﬁc
ER-resident oxidases, which do not directly introduce disulﬁdes into
newly synthesized proteins. These enzymes catalyze the ﬁrst step in di-
sulﬁde formation by transferring oxidizing equivalents to the PDI pro-
teins, which then introduce these disulﬁdes into nascent polypeptides
[32–35].4. ERO1 oxidative pathway
The ﬁrst of the ER oxidative pathways for de novo disulﬁde forma-
tion to be identiﬁed involves the ER oxidoreductin 1 protein (Ero1).
This enzyme was initially characterized in yeast where it was shown
to be essential for disulﬁde formation in PDIp [36,37]. Mammals and
other vertebrates have two Ero1 paralogs, namely: Ero1αwhich is pres-
ent in all tissues and Ero1β which shows some tissue speciﬁc expres-
sion [38,39]. The mammalian Ero1 proteins are able to complement
yeast Ero1p temperature-sensitive mutants [38]. The Ero1 proteins
are ﬂavoenzymes that use FAD as a cofactor to transfer electrons from
PDI to molecular oxygen, forming hydrogen peroxide in the process
[40–42]. Ero1 contains a cluster of cysteine residues responsible for its
catalytic cycle. A pair of cysteine residues, present on an unstructured
ﬂexible loop, and termed the shuttle cysteines, constitutes the ‘outer’
active site. At the C-terminus of the protein are two additional cysteines,
present in a CXXC motif, and lying in close proximity to the bound co-
factor FAD. These cysteines comprise the ‘inner’ active site. The ﬁrst
step in disulﬁde exchange between Ero1and PDI proteins involves the
ﬂexible loop shuttle cysteines which directly accept electrons from
PDI. Through an internal disulﬁde exchange reaction, these electrons
are shuttled to the ‘inner’ active site which pass them onto the FAD,
and ultimately onto the ﬁnal acceptor oxygen. In addition to disulﬁde
exchange reactions, the ﬂexible loop has been suggested to contain a
binding site for PDI [43].
While Ero1 activity is important for disulﬁde bond formation,
unregulated Ero1 could generate high concentration of hydrogen
peroxide, which could affect cell viability. Overexpression of a
deregulated yeast Ero1 mutant results in inhibition of cell growth [44]
while the overexpression of human Ero1α results in an unfolded protein
(stress) response [45]. Thus, the activity of the Ero1proteins are regulated
via a negative feedback mechanism that involves pairs of non-catalytic
cysteine residues that restrict the movement of the ‘outer’ shuttle disul-
ﬁde, thereby preventing disulﬁde exchange with the ‘inner’ active site
[41,43,44,46]. These regulatory disulﬁdes need to be reduced to activate
the enzyme and allow electron transfer between the active sites. One cur-
rent view is that PDI itself can regulate Ero1 activity by reducing the reg-
ulatory disulﬁdeswhen the ER PDI pool becomes predominantly reduced














































Fig. 1. Possible sequence of events during disulﬁde formation. Schematic depicting one potential scenario for the oxidative folding of an unfolded polypeptide in the presence of PDI.
PDI is known to bind to polypeptide chains within the bb′ domains at the base of its U-shaped open conformation (binding). Free thiols within the polypeptide can then form a
mixed disulﬁde with either active site of PDI (here depicted as via the a′ domain). The formation of this mixed disulﬁde would potentially prevent the formation of non-native
disulﬁdes which are less likely to form once the polypeptide folds which brings the correct disulﬁdes into close proximity (folding). A disulﬁde exchange reaction then takes
place, forming the disulﬁde within the substrate and reducing PDI. The substrate is then released as PDI changes conformation to the closed form.
Figure adapted from [2,27].
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PrxIV is an ER-localizedmember of the 2-cys peroxiredoxins, a family
of enzymes which protect cells from peroxide-induced oxidative stress
[48]. PrxIV utilizes H2O2 as a terminal electron acceptor and couples its
breakdown to disulﬁde bond formation in the PDI proteins [32,35].
Structurally, PrxIV is similar to other 2-cys peroxiredoxins, consisting of
ﬁve dimers arranged in a donut-like ring structure, with each polypep-
tide in the dimer containing an active site peroxidatic and a resolving
cysteine [49].
Indication of a role for PrxIV in disulﬁde formation came from a study
which showed that knockdown of PrxIV in MEFs lacking Ero1α/β
resulted in a lack of disulﬁde bond formation and subsequent cell death
[35]. This result was supported by an independent study which showed
that reduced PDI proteins can recycle the H2O2-induced disulﬁde bond
in PrxIV; thereby coupling H2O2-mediated oxidation to disulﬁde forma-
tion in substrate proteins [32]. In addition, mice deﬁcient of both Ero1
paralogs and PrxIV suffer from ascorbic acid deﬁciency probably caused
by reaction of H2O2 with this vitamin [50]. This result demonstrates
both the presence of H2O2 in the ER in the absence of Ero1 and the crucial
role played by PrxIV in metabolizing this reactive oxygen species.
The ﬁrst step in the breakdown of H2O2 involves the sulfenylation of
the peroxidatic cysteine (Cys 124) to sulfenic acid (SOH) which prompts
a conformation change allowing the modiﬁed peroxidatic cysteine, to
react with the nucleophilic resolving cysteine (Cys 245), resulting in an
interchain disulﬁde bond. This disulﬁde can be reduced by PDI proteins,
including PDI, ERp46 and P5, via a typical thiol-disulﬁde exchangemech-
anism [32]. The PrxIV pathway ensures that for every oxygen molecule
consumed during Ero1-mediated oxidation of PDI proteins, two disulﬁde
bonds can be generated in newly synthesized proteins. The sulfenylated
cysteine can be further oxidized to the sulﬁnic (SO2H) or even sulfonic(SO3H) acid. While the sulfonic acid form is irreversible, in the cytosol
the sulﬁnic acid can be reduced by the ATP-dependent sulﬁredoxin [51].
Whether a similar reaction can occur within the ER is debatable as to
date no ER localized sulﬁredoxin has been identiﬁed.
The catalytic activities of the Ero1 proteins generally contribute to
the ER H2O2 pool under normal physiological conditions. While the
Ero1-generated peroxide appears to be important for the oxidation of
PrxIV [52], the enzyme also utilizes other sources of H2O2 as clearly
suggested from studies of double Ero1 knockout MEFs [35]. Although
the origin of this H2O2 is currently obscure, potential sources include
mitochondria respiration, the peroxisomal oxidation of fatty acids and
the enzymatic activities of the ER-localized NADPH oxidase [53].
6. Glutathione peroxidase7/8 pathway
The glutathione peroxidases (GPxs) are found in all forms of life and
generally utilize GSH for the reduction of H2O2. So far eight GPXs have
been identiﬁed in humans, including the ER-localized GPx7 and GPx8
[34]. Although classiﬁed as GPxs, both GPx7 and GPx8 exhibit poor glu-
tathione peroxidase activities, but have been shown to exhibit PDI per-
oxidase activity. Both enzymeswere shown to interact with Ero1 and to
promote the introduction of disulﬁde bonds into reduced substrates in
the presence of PDI andH2O2 [34]. These reactions suggest an important
role for these proteins in disulﬁde bond formation. As typical peroxi-
dases, it is possible that GPx7 and GPx8 reaction mechanism proceeds
via a sulfenylated cysteine intermediate formed by the oxidation of
the active site cysteine by H2O2. The sulfenylated cysteine could then
react with a reduced cysteine in the PDI active site, to form a transient
mixed-disulﬁde bond. The mixed disulﬁde is resolved by the second
cysteine in the PDI CXXC, to yield a disulﬁde bond in PDI and reduced
GPx. An alternative mechanism has recently been proposed whereby
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form an intra-chain disulﬁde. The intrachain disulphide could then be
reduced by PDI thereby recycling Gpx7/8 for further rounds of reaction
with H2O2. Such a mechanism has recently been suggested for Gpx7
[54] although in this work Gpx7 is reported to catalyze the formation
of a disulﬁde bond within the ER chaperone BiP thereby enhancing its
chaperone activity.
7. Vitamin K epoxide reductase (VKOR) pathway
The VKOR enzyme provides an additional pathway for disulﬁde bond
formation. Homologues of the humanenzymehave been identiﬁed in nu-
merous organisms,where they are implicated indisulﬁde bond formation
[55]. VKOR is an important component of the ER membrane-resident vi-
tamin K-dependent γ-carboxylation system which plays a key role in
blood coagulation. It is a polytopic transmembrane protein, containing
two conserved cysteine pairs; one that is membrane embedded, and
the other present on a loop region. These cysteines catalyze redox reac-
tions as part of the catalytic cycle. VKOR reduces vitamin K or its epoxide
derivative resulting in the formation of a disulﬁde in the membrane-
embedded CXXC motif. Recycling of the enzyme involves a disulﬁde
exchange reaction between the CXXC disulﬁde and a cysteine pair
in the loop region [55], which ultimately can accept electrons from
thioredoxin-like proteins [55,56]. Conﬂicting membrane topologies,
with implications for the location of the conserved loop cysteines,
have been proposed for human VKOR. In the four transmembrane
helix model the loop cysteines are exposed in the ER lumen and can,
therefore, accept electrons from PDI family proteins [55]. In support of
this model, VKOR was shown to form mixed disulﬁdes with PDI-like
proteins. Speciﬁcally, it was reported to interactwith themembrane an-
chored TMX and less so with the closely-related TMX4 and the soluble
ERp18 [55]. In contrast, the three transmembrane helix model places
the loop cysteines in the cytosol,making cytosolic thioredoxin the likely
electron donor [57,58]. On reduction of vitamin K or its epoxide, the
membrane-embedded Cys132 and Cys135 of the CXXC motif become
oxidized [59,60]. The CXXC disulﬁde accepts electrons from the loop
Cys43 and Cys51 pair, which become oxidized. Ultimately, the Cys43–
Cys51 disulﬁde is transferred to thioredoxin-like proteins.
Support for a role of the VKOR pathway in disulﬁde formation comes
from a study of the consequence of knockdown of the enzyme in combi-
nationwith an Ero1 knockdown [33].While depletion of VKORon its own
hadminimal effects, a combination of Ero1α and β depletionwith VKOR
caused a more severe delay in disulﬁde formation than Ero1 α and β
alone. In addition, VKOR was able to support the recovery of cells from
a reductive challenge in the near absence of the Ero1 paralogues and
PrxIV.
8. Conclusion
The past two decades have seen an increase in our understanding of
the various components and enzymatic pathways that operate in the
ER. In this time, it has become apparent that multiple pathways exist
to accomplish disulﬁde bond formation in the ER. Importantly, the real-
ization that H2O2 can be utilized to generate disulﬁdes in newly synthe-
sized proteins has to some extent, clariﬁed how cells alleviate oxidative
stress.While our understanding of the basicmechanisms involved in di-
sulﬁde bond formation has no doubt increased, a number of important
questions remain unanswered. Signiﬁcantly, the speciﬁc roles of the in-
dividual enzymes and components remain obscure. Furthermore, is
there a functional relationship between the various oxidative path-
ways? Whereas the PDI proteins have been identiﬁed as key players
in disulﬁde formation, their speciﬁc functions remain unknown. Do
these proteins function singly or together in large multi-protein com-
plexes? Although some studies have identiﬁed speciﬁc functions for
some PDIs and preference for somemembers by certain oxidative path-
ways [32,55], a detailed characterization is necessary to understandtheir unique roles not only in disulﬁde formation but in general ER qual-
ity control.
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